PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
Enterprise IntelligenceQuarterly drug-development signals, programme moves, and catalysts.ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Compound Leaderboard

Psychedelic compounds ranked by research activity.

1Ketamine
450
2Psilocybin
332
3MDMA
139
4Esketamine
96
5LSD
51
6DMT
25
75-MeO-DMT
17
8Ayahuasca
16
9Ibogaine
8
102C-X
2
11Mescaline
2

11 compounds with clinical trials data

Explore all compounds →

Blossom Research Snapshot

moreblossom.com

Clinical trials, participants, and published papers across all therapeutic topics in psychedelic science.

Topic
Depressive Disorders
601
60,559
1,228
Major Depressive Disorder (MDD)
315
28,768
397
Treatment-Resistant Depression (TRD)
211
20,475
348
Bipolar Disorder
51
6,662
125
Peripartum
18
2,886
8
Premenstrual Dysphoric Disorder (PMDD)00
2
Neuroimaging & Brain Measures
233
12,205
407
Healthy Volunteers
225
12,779
439
PTSD
122
10,361
351
Anxiety Disorders
110
11,871
772
Palliative & End-of-Life Distress
53
2,271
184
Substance Use Disorders (SUD)
109
7,003
570
Alcohol Use Disorder (AUD)
46
3,214
111
Opioid Use Disorder (OUD)
25
1,476
40
Tobacco/Nicotine Use Disorder (TUD)
5
257
64
Suicidality
94
10,988
243
Chronic Pain
80
6,209
174
Headache Disorders (Cluster & Migraine)
15
582
89
Fibromyalgia
11
461
5
Safety & Risk Management
72
3,632
328
Set & Setting
53
2,517
156
Interpersonal Functioning & Social Connectedness
35
1,365
179
Topic
Neurocognitive Disorders
32
2,944
97
Veterans
31
1,268
53
Implementation & Service Delivery
29
2,344
31
Adolescents
19
989
132
Neurological Injury
19
1,370
29
Traumatic Brain Injury (TBI)
12
1,015
13
Eating Disorders
18
461
35
Obsessive-Compulsive Disorder (OCD)
18
1,607
76
Immunology & Inflammation
14
551
101
Older Adults
14
2,204
66
Medicinal Chemistry & Drug Development
13
267
193
Microdosing
13
416
132
Schizophrenia
9
1,501
205
Autism Spectrum Disorder (ASD)
8
216
27
Health Economics & Reimbursement
7
959
30
Personality & Trait Factors
6
1,148
149
Personality Disorders
6
210
19
Borderline Personality Disorder (BPD)
5
198
12
Equity and Ethics
5
167
125
Public Health, Prevention & Behaviour Change
5
484
124
Creativity
4
204
88